{"organizations": [], "uuid": "336b3ec3b366d62c0751da94c636ab098504f4a3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180205.html", "section_title": "Archive News &amp; Video for Monday, 05 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fibrocell-science-says-expect-to-i/brief-fibrocell-science-says-expect-to-initiate-a-safety-clinical-trial-in-2018-for-fcx-013-development-idUSFWN1PV0WN", "country": "US", "domain_rank": 408, "title": "BRIEF-Fibrocell Science Says‍ Expect To Initiate A Safety Clinical Trial In 2018 For Fcx-013 Development", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.314, "site_type": "news", "published": "2018-02-05T21:33:00.000+02:00", "replies_count": 0, "uuid": "336b3ec3b366d62c0751da94c636ab098504f4a3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fibrocell-science-says-expect-to-i/brief-fibrocell-science-says-expect-to-initiate-a-safety-clinical-trial-in-2018-for-fcx-013-development-idUSFWN1PV0WN", "ord_in_thread": 0, "title": "BRIEF-Fibrocell Science Says‍ Expect To Initiate A Safety Clinical Trial In 2018 For Fcx-013 Development", "locations": [], "entities": {"persons": [], "locations": [{"name": "cal", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fibrocell science inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 5 (Reuters) - Fibrocell Science Inc:\n* FIBROCELL SCIENCE SAYS‍ EXPECT TO INITIATE A SAFETY CLINICAL TRIAL IN 2018 FOR FCX-013 DEVELOPMENT - SEC FILING​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-05T21:33:00.000+02:00", "crawled": "2018-02-06T23:53:26.003+02:00", "highlightTitle": ""}